|
|||||
A report by a pharmaceutical industry organization says nearly 300 new therapies that transfer live cells or genes as treatments for disease are in clinical trials or being reviewed by Food and Drug Administration. . . . → Read More: Report – 289 Cell and Gene Therapies in Development 
A tiny wireless sensor chip measuring exposure to ultraviolet or UV rays from the sun, developed by a university lab, is now offered by a cosmetics company with an accompanying smartphone app. . . . → Read More: Self-Powered Sun Exposure Chip, App Developed 
A collaboration of Mount Sinai medical center, drug maker Sanofi, and data science company Sema4 aims to track people with asthma for 5 years to help develop personalized treatments for the disease. . . . → Read More: Mount Sinai, Sanofi, Sema4 Partner on Long-Term Asthma Study 
Chip devices with human immune system and stem cells are among the cargo set for launch today to the International Space Station. . . . → Read More: Immune Cell Chips to Launch into Space for Microgravity Tests 
The Food and Drug Administration identified a public database of genomics and diseases as a resource to assess new diagnostics tests using genetic data for precision medicine. . . . → Read More: FDA Identifies Database to Evaluate Precision Diagnostics 
Results from the first 2 participants in a clinical trial show transferring healthy genes to patients with sickle cell disease reverses symptoms of the disease that continues for up to 1 year. . . . → Read More: Trial Results Show Gene Transfers Reverse Sickle Cell Disease 
Electrodes sent into a blood vessel in the brain with a catheter and stent are shown in tests with sheep to stimulate muscles in the animals’ faces and limbs. . . . → Read More: Electrode in Brain Blood Vessel Shown to Stimulate Body Muscles 
An affiliate of drug maker Janssen Pharmaceutical is licensing a synthetic antibody to treat blood-related cancers from a developer of antibodies based on the immune system of llamas. . . . → Read More: Janssen Licensing Cancer Antibodies in $1.8B Deal If a machine can carry out a delicate surgical task on something as vulnerable and soft as a grape, we begin to wonder whether such machines could be put to work on people too. . . . → Read More: The Resurgence of “They Did Surgery on a Grape” 
Editas Medicine received the go-ahead to conduct a clinical trial using the genome editing technique Crispr. . . . → Read More: Recap – Editas Medicine Advances Crispr Therapy  Comments are closed  New products, Regulations  biomedical, biotechnology, engineering, entrepreneurs, life sciences, physical sciences |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
